Lumexa Imaging Holdings, Inc. Common Stock (LMRI) Stock Score, Valuation & Financial Research
Lumexa Imaging Holdings, Inc. Common Stock is in the Healthcare sector and Medical - Devices industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 27/100.
Quick answer for LMRI
Lumexa Imaging Holdings, Inc. Common Stock currently has a Wall Street Score of 27/100. The stored market price is $11.65. Its financial score is 50/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.
What Lumexa Imaging Holdings, Inc. Common Stock does
Lumexa Imaging Holdings, Inc. manages and operates diagnostic imaging centers throughout the United States. These facilities deliver a comprehensive range of outpatient medical imaging solutions, encompassing advanced procedures like Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and Positron Emission Tomography (PET) scans, in addition to standard diagnostic and screening services such as X-rays, ultrasounds, and mammography. The company was founded in 2018 and its primary base of operations is in Raleigh, North Carolina.
LMRI financial snapshot
- Wall Street Score:
- 27/100
- Current price:
- $11.65
- Market capitalization:
- $1.12B
- Revenue:
- $1.02B
- Net income:
- $-47.1M
- Free cash flow:
- $-6.4M
- Cash:
- $51.2M
- Total debt:
- $967.5M
- EPS:
- -0.66
- Financial score:
- 50/100
- Valuation score:
- 0/100
- Revenue score:
- 21/100
What stands out
- Reported year-over-year revenue growth is +0.1%.
- Free cash flow is $-6.4M, showing cash burn in the current stored period.
- The balance sheet shows $51.2M of cash versus $967.5M of total debt, so leverage deserves attention.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 50/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research LMRI
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.